Ritanserin as add-on medication to neuro
β
J. A. Den Boer; J.-O. Vahlne; P. Post; A. H. Heck; F. Daubenton; R. Olbrich
π
Article
π
2000
π
John Wiley and Sons
π
English
β 980 KB
The effect of ritanserin, a potent 5HT 2A/2C receptor antagonist, used as an add-on medication to neuroleptic treatment in patients with schizophrenia, was compared with that of placebo, in an international, double-blind, parallel-group study. Previously established neuroleptic therapy was maintaine